Hemispherx Reports 2018 Third Quarter and First Nine Months Financial Results Pharmaceutical Investing
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 Pharmaceutical Investing
Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 Pharmaceutical Investing
Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma Life Science Investing
Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
